Picture of Modus Therapeutics Holding AB logo

MODTX Modus Therapeutics Holding AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Modus Therapeutics Holding AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
SAS
SAS
SAS
SAS
SAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-43.6-6.02-20.7-18-16.4
Non-Cash Items-0.0010.001-0.00100.003
Other Non-Cash Items
Changes in Working Capital-4.32-1.214.61-3.72-0.286
Change in Accounts Receivable
Change in Other Liabilities
Cash from Operating Activities-47.9-7.23-16.1-21.7-16.7
Capital Expenditures-0.0160
Purchase of Fixed Assets
Other Investing Cash Flow Items-0.0500
Purchase of Investments
Cash from Investing Activities-0.0160-0.0500
Financing Cash Flow Items-0.050-3.690-1.04
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities3.513.229.411.525.3
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-44.45.9713.3-10.28.64